Loading the company…
Loading the company…
In the last ten years FDA made 7 decisions for Neotract (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2020 (2). The latest was on 2023-09-22.
| Family | Decisions on record |
|---|---|
| BPH procedures | 11 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2023-09-22 | 510(k) | K232558 | UroLift 2 ATC Advanced Tissue Control System |
| 2020-07-31 | 510(k) | K201837 | UroLift 2 System (formerly UL500), UroLift 2 Delivery Handle, UroLift 2 Implant Cartridge |
| 2020-06-05 | 510(k) | K200441 | UroLift Advanced Tissue Control (ATC) System |
| 2019-12-20 | 510(k) | K193269 | UroLift System (UL400) |
| 2019-03-21 | 510(k) |
| K190377 |
| UroLift System UL400 |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Neotract.